The incidence of mammary adenocarcinoma in Sprague-Dawley female rats, caused by the carcinogen 7,12-dimethylbenz(cw)anthracene, was influenced by the level of dietary fat fed after exposure to carcinogen. Carcinogen was given by stomach tube to SO-dayold rats, and tumors were evaluated when rats were 9 months old. Rats on diets containing 20% unsaturated fat had a tumor incidence of 97%. while rats changed to a low-fat diet (2% unsaturated fat) three or four weeks after exposure to the carcinogen had an incidence of 45%. Some rats on each diet were given two treatments with the methanol extraction residue of Bacillus Calmette-Guerin, either three and five weeks after carcinogen or four and six weeks after carcinogen. Tumor incidence in the treated group and the untreated group was the same when rats were maintained on the high-fat diet, but tumors in the treated group were larger and the disease was more severe by histological criteria. These tumors were more anaplastic and many were extensively infiltrated with lymphocytes compared to the untreated group. Tumor incidence was significantly lower in rats changed to the low-fat diet (45%) than in those on the high-fat diet (97%), and tumor incidence was reduced to 20% when rats changed to the low-fat diet were treated with methanol extraction residue. The treated group had less severe disease than the untreated group on the low-fat diet. Only half the tumor-bearing rats in this group had malignant tumors, and none were invasive. Methanol extraction residue protected most rats on the low-fat diet against mammary adenocarcinoma, and reduced the severity of disease in those rats that did develop tumors. Methanol extraction residue treatment provided no protection, and even increased the severity of disease, in rats on the high-fat diet.
Immune stimulants have been used as prophylactic and therapeutic agents in many animal tumor-host systems to determine how these agents influence tumor incidence, growth, or metastasis. The resulting data indicate that immune stimulants may be protective [24, 31, 321 , may have no effect [27] , or may be deleterious [5, 17, 18, 281 . While some of these differences may be attributed to the tumor-host systems being studied, within the same system the results are influenced by the dose of immune stimulant [8, 26] , the route of injection [4, 161, and the time of treatment [2, 7, 16, 251 with respect to tumor implant or exposure to the carcinogen. For example, rats were protected against mammary tumors by immunization with a mouse C-type virus seven days before exposure to carcinogen [34] . Immunization 20 to 30 days before exposure to the carcinogen was not protective. Using the same model, we reported [2 11 that treatment with methanol extraction residue before exposure to carcinogen also protected rats against mammary carcinoma. In these studies tumor incidence was dependent on dietary fat, and protection with residue treatment was limited by dietary fat. When methanol extraction residue was given after exposure to the carcinogen, protection was attained only in rats on a low-fat diet. Tumors in rats on a high-fat diet grew more rapidly than in untreated rats on the same diet.
High-fat diets, particularly diets containing high levels of unsaturated fat, increased the incidence of carcinogen-induced mammary adenocarcinoma [9, 10, 1 I, 141. The latent period was relatively short, tumor growth was more rapid, multiple tumors appeared more frequently, and the total tumor mass was greater in rats on the highfat diet than in rats on the low-fat diet [ 19, 231 . Treatment with methanol extraction residue accentuates these differences. Tumors that are influenced by dietary fat and inhibited or enhanced by residue treatment had not been studied histologically. The purpose of our study was to determine how the histological properties of mammary adenocarcinoma compared with tumor incidence and tumor growth rates in rats in which the quantity of dietary fat and treatment with an immune stimulant were being evaluated.
Materials and Methods
Sprague-Dawley female rats were used for these studies. Weanlings, 21 days old, from the Charles River Colony (Wilmington, Mass.), were placed on a 20% unsaturated fat diet (ICN Pharmaceuticals, Inc., Life Sciences Group, Cleveland, Ohio). Three weeks after exposure to a single dose of 7,12-dimethylbenz(a)anthracene, at 50 days of age, rats were divided into four groups of 64 rats each as follows: Group I was maintained on the 20% unsaturated fat diet and was not treated; group I1 was maintained on the 20% unsaturated fat diet, and treated with methanol extraction residue; group I11 was changed to the low-fat diet, but was not treated; group IV was changed to the low-fat diet and treated with residue. All rats were palpated for tumors for 30 weeks after exposure to carcinogen. Then all rats were killed, and individual tumors were excised, weighed and fmed in 10% buffered formalin.
Diets were sealed in plastic bags and stored at 4°C until fed. They were prepared in accordance with our specifications, and routine analysis of each new shipment showed that these diets contained consistent levels and types of fatty acids from batch to batch. The contents of each diet per 100 grams of diet were: Diets were fed ad libitum and were not isocaloric. Based on caloric density and amount of diet consumed per day, however, the daily caloric intake was similar for all groups. Growth curves indicated no differences between rats on either diet [ 191.
All rats were given a single dose of 10 mg of 7,12-dimethylbenz(a)anthracene, (Sigma Chemical Co., St. Louis, Mo.) in 1 ml of stripped corn oil via stomach tube at 50 days of age. Control rats, not exposed to 7,12-dimethylbenz(a)anthracene, were not included in this experiment because previous experiments [22] indicated that spontaneous tumors did not develop in rats maintained on either diet during this period of observation.
All rats in groups I1 and IV were given two intraperitoneal injections, two weeks apart, of 0.5 mg methanol extraction residue of Bacillus Calmette-Guerin (National Cancer Institute, Silver Spring, Md.) in 0.2 ml of vehicle. Rats in groups I and I11 were treated with 0.2 ml of vehicle only. Half the rats in each group were treated at three and five weeks after carcinogen, the other half at four and six weeks after carcinogen. Vehicle contained the following per mi of water: 9 mg sodium chloride, 5 mg sodium carboxymethylcellulose, 0.004 ml of polysorbate, and 0.009 ml of benzyl alcohol. Tumors (all adenocarcinomas) excised from these four groups of rats were stained with hematoxylin and eosin (HE) or periodic acid-Schiff (PAS) and hematoxylin. In group I, we evaluated 3 1 tumors from 16 rats; in group 11, 38 tumors from 22 rats; in group 111, 30 tumors from 17 rats; and in group IV, 3 1 tumors from 27 rats. The following histological criteria were used to assess the biologic behavior of these tumors and the host response: anaplasia; invasiveness in adjacent muscle, fat or dermis; benignity or malignancy; and infiltration with lymphocytes. Slides were coded so that dietary state, treatment and group were not known by the pathologist at the time of evaluation.
Tumor incidences in the various groups were compared by chi-square analysis. The average number of tumors per tumor-bearing rat in the different groups was evaluated with a Kruskal-Wallis one-way analysis of variance. Differences in total tumor mass per tumor-bearing rat and average tumor mass per group were determined with Student's t test.
Results
Tumor incidence was similar in both groups maintained on the high-fat diet, and nearly all rats in both groups had two or more tumors (table I) . The average tumor mass per tumor-bearing rat, however, was significantly higher (p I .05) in the group treated with methanol extraction residue. This was due entirely to the larger mass of individual tumors in the treated group compared to the untreated group (p 5 .O l), and not to differences in the average number of tumors per tumor-bearing rat.
Untreated rats changed to the low-fat diet had a significantly lower tumor incidence (p 5 .05), and fewer rats had multiple tumors (p 5 .Ol), compared to untreated rats on the high-fat diet. These groups were not different, however, in the average number of tumors or average tumor mass per tumor-bearing rat. When rats on the low-fat diet were treated with residue, tumor incidence was decreased (p 5.05) compared to the non-treated group on this diet. While there were also fewer rats with multiple tumors in the treated group (p 5 .05), the average number of tumors and average tumor mass per tumor-bearing rat were similar in both groups on the low-fat diet.
The data in table I1 show that histological findings were consistent with tumor incidence and severity of disease as measured by other criteria. Rats with the largest tumor mass (those maintained on 20% unsaturated fat diet and treated with residue) carcinogen; the other half at four and six weeks after carcinogen.
four weeks after carcinogen. ' Half the rats had methanol extraction residue treatment at three and five weeks after ' Half the rats were changed to the low fat diet three weeks after carcinogen; the other half ' These characteristic tumors were evaluated in rats selected randomly.
carcinogen; the other half at four and six weeks after carcinogen.
four weeks after carcinogen.
also had the highest frequency of anaplasia ( fig. 1) . These tumor cells were arranged haphazardly, varied considerably in size, and had a high mitotic index. Tumors from both groups maintained on the high-fat diet were more invasive than tumors from rats on the low-fat diets (fig. 2 ). These tumors also invaded adjacent fat and dermis. Figure 3 illustrates the infiltration of lymphocytes within the tumor, seen most frequently in tumors from residue-treated rats on the high-fat diet. No effort was made to characterize these lymphocytes in terms of surface markers, type or function.
Except for tumors from the residue-treated group on the low-fat diet, most tumors showed secretory activity ( fig. 4) . Their cells were characterized by large vacuoles and secretory fluid in the tubule lumen.
The greatest histological differences were seen in residue-treated rats on the different diets (table 11). Differences between untreated rats on these diets were not remarkable. Since both groups were exposed to the carcinogen while on the high fat diet, however, this histological profile may not be consistent with the histological profile of rats maintained on either diet continuously from the time of weaning.
Discussion
The consequences of treating animals with immune stimulants depend, at least in part, on time of therapy. We reported previously that methanol extraction residue protected rats against carcinogen-induced mammary tumors, if treatment was given before exposure to carcinogen [21] . Methanol extraction residue reduced the tumor incidence from 97% to 45% in rats maintained on the high-fat diet, and from 36% to 9% in rats on the low-fat diet. In the present study, treatment was given after exposure to carcinogen. While rats changed to the low-fat diet were protected by residue, rats maintained on the high-fat diet were not protected; in fact, this group developed more severe disease and their tumors grew more rapidly than those of untreated controls. While rats in the present studies were six weeks older than rats in the prophylactic study 1211, they had been exposed to carcinogen three or four weeks earlier. Hence, most of these rats probably had micro-foci of developing tumors at the time of residue treatment. Other studies indicate that mitogen-induced blastogenesis was inhibited by serum factors in rats maintained on the high-fat diet [22] . Consequently, stimulation of immune-suppressed rats may prolong or intensify suppression, resulting in more rapidly growing tumors. Other workers [6] have reported that progressive tumor growth was accompanied by the appearance of blocking factors (antibodies or antigen-antibody complexes) in serum. Titres of blocking factors may increase in animals treated with immune stimulants. These factors may completely abrogate potential benefits associated with cell-mediated immunity. Treatment of rats with antilymphocyte serum increased tumor incidence and number of tumors per tumor-bearing rat [ 12, 331. In addition, invasion of tumor into adjacent muscle and dermis was notable in rats treated with antilymphocyte serum, compared to controls. Lymphocyte infiltration of primary tumors and histiocyte proliferation in regional lymphoid sinuses are associated with a good prognosis in a number of solid tumors, and the absence of such cellular infiltrations and proliferation is associated with a worse prognosis [13] . This is particularly true in certain diseases, such as breast cancer, in which this type of cellular response is more important than other prognostic factors, such as the number of lymph nodes involved. The macrophage content of tumors has been investigated recently. A high macrophage content has good prognostic implications [ 1 ]. We also have observed that the concentration of peritoneal macrophages was increased by treatment with methanol extraction residue before exposure to carcinogen in rats maintained on the high-fat diet (Kollmorgen, unpublished) . It is not known, however, whether this increase in macrophage concentration is adequate or necessary for protecting rats against tumors.
The correlation between anaplasia and rate of tumor growth has been reported [3, 201. In addition, the more malignant mammary tumors tended to be more anaplastic and infiltrated with lymphocytes, and frequently displayed secretory activity (J. Russo and I. H. Russo, personal communication, 1980) . While chemotactic factors [30] may attract lymphocytes into areas of tumor [29] , it cannot be assumed that these lymphocytes are capable of killing tumor cells. In fact, the accumulation of many lymphocytes in tumors taken from residue-treated rats on the high-fat diet suggests that these lymphocytes did not function as killer cells. This is consistent with other data that indicate that high-fat diets inhibit lymphocyte function. Their presence, however, does not account for the rapid rate of tumor growth, unless tumor growth is enhanced by the microenvironment associated with or produced by these lymphocytes. Additional experiments are required to determine whether the absence of functional lymphocytes or the presence of growth-stimulating factors accounts for the observations reported in this study.
